Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Vinay Singh joined Burrill & Company in 2011 and became a researcher and writer in the media group at the start of 2012. He moved to the Burrill Securities as an analyst in January of 2013. Prior to joining Burrill & Company, Mr. Singh worked as a volunteer at the University of California, San Francisco Hospital in the emergency room and in the childcare services All-Star room with pediatric cancer patients. Mr. Singh also served as a research associate summer intern at Exelixis in the new drug discovery group focusing on high-throughput compound screening. He is a graduate of Lehigh University with a BS in biology/pre-medicine.